Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
EirGenix, Inc. logo — Clients'​ Success Is Our Priority

EirGenix, Inc.

Clients'​ Success Is Our Priority

Founded 2012 Taiwan Taiwan 220 employees Post Ipo Equity Health Care, Manufacturing

General Information

Company Name EirGenix, Inc.
Founded Year 2012
Location Taiwan Taiwan +2
Employees 220
Industries Health Care, Manufacturing
Funding Stage Post Ipo Equity
Social

Get notified when EirGenix, Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About EirGenix, Inc.

EirGenix, Inc. is a Taiwan-based contract development and manufacturing organization focusing on providing high-quality and cost-effective services in the field of biopharmaceuticals. Established in 2012, the company's slogan "Clients'​ Success Is Our Priority" reflects its commitment to client satisfaction. EirGenix offers a range of services including cell line development, process optimization, analytical services, and quality control, with a specialization in biosimilars and antibody-drug conjugate (ADC) development and manufacturing. Notably, the company has received approvals from regulatory bodies such as the Taiwan FDA and Japan PMDA, while awaiting inspections from the U.S. FDA (June 2022) and EMA (2022-2023). In a recent development, EirGenix secured a significant Post-IPO Equity investment on 15 August 2022, with the investment coming from Taiwania Capital Management Corporation. This investment is indicative of the company's potential for growth and its attractiveness to investors within the Health Care and Manufacturing industries. EirGenix's strategic location in Taiwan, a hub for the healthcare and biotechnology sectors, positions it favorably for further expansion and collaboration in the global market.

Taxonomy: biopharmaceuticals, contract development, manufacturing organization, biologics, biosimilars, cell line development, process development, analytical services, cGMP manufacturing, antibody-drug conjugate, FDA inspected/approved, Taiwan FDA

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Equity •••••• 1
Investor
15 Aug 2022
Post-IPO Equity •••••• 1
Investor
15 May 2020
Post-IPO Equity •••••• 1
Investor
31 Oct 2018

EirGenix, Inc. Alternatives & Competitors

EirGenix, Inc. vs
Northway Biotech
Northway Biotech Lithuania

Biologics CDMO located in Waltham, MA, and Vilnius, Lithuania

Unknown
160 employees
Biotechnology
Compare EirGenix, Inc. vs Northway Biotech
EirGenix, Inc. vs
Polaris Pharmaceuticals Inc.
Polaris Pharmaceuticals Inc. United States

We specialize in proteins derived from microbial hosts and support PD, Pre-Clinical and clinical man...

86 employees
Biopharma, Biotechnology
EirGenix, Inc. vs
Singota Solutions
Singota Solutions

Focused on Faster

79 employees
Pharmaceutical, Supply Chain
Also compare with: EirGenix, Inc. vs Excite Pharma Services Excite Pharma Services EirGenix, Inc. vs ASolution Pharmaceuticals Pvt. Ltd. ASolution Pharmaceuticals Pvt. Ltd.

FAQ About EirGenix, Inc.

Clients'​ Success Is Our Priority
EirGenix, Inc. was founded in 2012.
EirGenix, Inc. is headquartered in Taiwan.
EirGenix, Inc. operates in the following industries: Health Care, Manufacturing.
EirGenix, Inc. has approximately 220 employees.
EirGenix, Inc. has completed 3 funding rounds. The latest funding stage is Post Ipo Equity.
Top alternatives and competitors to EirGenix, Inc. include Northway Biotech, Polaris Pharmaceuticals Inc., Singota Solutions, Excite Pharma Services, ASolution Pharmaceuticals Pvt. Ltd.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
EirGenix, Inc. and Northway Biotech are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors EirGenix, Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy